Last reviewed · How we verify

NCT06619327: RT-D

Resilient Together for Dementia (RT-D)

Recruiting now NA Last updated 15 April 2026
What this trial tests

NA trial testing Resilient Together for Dementia in Dementia in 50 participants. Currently enrolling.

Timeline
19 February 2025
Primary endpoint
30 August 2026
30 June 2027

Quick facts

Lead sponsorIcahn School of Medicine at Mount Sinai
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment50
Start date19 February 2025
Primary completion30 August 2026
Estimated completion30 June 2027
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Icahn School of Medicine at Mount Sinai

Who can join

18 and older, any sex, with Dementia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will evaluate the feasibility and preliminary efficacy of the novel Resilient Together for Dementia (RT-D) intervention for couples following dementia diagnoses. The primary target is emotional distress, and the program aims to prevent chronic distress in at-risk couples.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Resilient Together for Dementia

Trials testing the same drug.

Other recruiting trials for Dementia

Currently open trials in the same condition.

Other Icahn School of Medicine at Mount Sinai trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06619327.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing